Acadian Asset Management LLC Acumen Pharmaceuticals, Inc. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 18,643 shares of ABOS stock, worth $48,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,643Holding current value
$48,658% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ABOS
# of Institutions
77Shares Held
41.7MCall Options Held
57.7KPut Options Held
70.6K-
Ra Capital Management, L.P. Boston, MA14.9MShares$39 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$9.26 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$8.92 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$6 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$5.63 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $106M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...